Skip to contentM
Medtronic plc
M
MDTMedtronic plc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$8.93B$8.93Bderived+3.9% vs Q4 2024 Net Income$1.06B$1.06Bderived+61.5% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medtronic plc · CIK 1613103 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$1,436,000,000+36.4% Operating Cash Flowderived$2,528,000,000−9.0% Free Cash Flowderived$2,069,000,000−12.0% Margins · derivedOperating margin16.1%+3.8 pt vs Q4 2024
Net margin11.8%+4.2 pt vs Q4 2024
ended Apr 25, 2025 · filed Jun 20, 2025 · 56 d after period end